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ABSTRACT
Background: Splenectomy has 50% to 70% long-term
efficacy for immune thrombocytopenic purpura (ITP). In
some patients, relapse is due to the presence of residual
accessory splenic tissue.
Methods: A 44-year-old male had ITP since 1983 with
splenectomy in 1985. He had a transient response, but
then developed severe thrombocytopenia refractory to
multiple modalities for 20 years. An accessory spleen was
first visualized in 2000.
Results: A laparoscopic accessory splenectomy was per-
formed without difficulty. The patient had an initial re-
sponse with a significant increase in platelet count. Al-
though over time the thrombocytopenia recurred, there
has been a long-term benefit in that the patient is on much
lower doses of prednisone to maintain an adequate plate-
let count.
Conclusion: The finding of accessory splenic tissue after
prior splenectomy may be an increasingly common prob-
lem in patients with recurrent ITP. Although reported
response rates for resection of residual splenic tissue vary,
the availability of a safe, less morbid, minimally invasive
approach makes the decision to operate easier.
Key Words: Thrombocytopenia, ITP (immune thrombo-
cytopenia), Splenectomy, Laparoscopic surgery.
INTRODUCTION
Excluding trauma, immune thrombocytopenic purpura
(ITP) is the most common indication for splenectomy in
the United States.1 In adult patients, splenectomy is an
attractive therapeutic option for those who fail to respond
to 4 weeks to 6 weeks of medical therapy with steroids or
other agents, who require toxic medication doses to main-
tain remission, or who relapse following an initial re-
sponse to medical therapy. This therapy is highly effica-
cious because the spleen is the major site for clearance of
antibody-coated platelets and also a primary site for plate-
let autoantibody production.2 Numerous prospective and
retrospective studies have found early response rates be-
tween 80% to 89% and long-term remission rates of 50% to
70% following splenectomy for treatment of ITP.3–6 Pa-
tients failing splenectomy generally require long-term im-
munosuppressive therapy. A subgroup of patients that
initially responded to splenectomy will have residual ac-
cessory splenic tissue discoverable at relapse. As illus-
trated by our case, these patients may be candidates for
further surgical therapy, and the decision to operate may
be made easier by the availability of minimally invasive
laparoscopic techniques.
METHODS
A 44-year-old male from Argentina presented with ITP in
1983 and underwent splenectomy in 1985. There was an
adequate response for 2 years, but then bleeding and
severe thrombocytopenia recurred. The disease proved
resistant to multiple attempted therapeutic interventions,
including danazol, pulse high-dose dexamethasone, vin-
cristine, cyclosphosphamide, dapsone, mycophenolate,
colchicine, and rituximab. There would be very brief (few
days) partial responses to high-dose intravenous immu-
noglobulin. Platelets were usually less than 10x 10
9/L, and
prednisone 20 mg to 30 mg daily was continued because
it seemed to reduce bleeding manifestations. These man-
ifestations were mainly bruising and gum bleeding, but
diverticular bleeding on one occasion required red blood
cell transfusions. In 2000, a small accessory spleen was
detected on computed tomographic (CT) scan, and this
was treated with small doses of radiotherapy.
The patient was evaluated in Houston in March 2005, at
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CASE REPORTwhich time platelet counts were 5x10
9/L and 17x10
9/L.
Peripheral blood smear showed few acanthocytes and
only very rare Howell-Jolly bodies. A CT scan and tech-
netium radionucleide liver-spleen showed an accessory
spleen that had grown to about 38 mm (Figure 1). After
discussion of therapeutic options, a decision was made to
proceed with a laparoscopic accessory splenectomy. The
patient was pretreated with IVIG 2 g/kg, which raised the
preoperative platelet count to 84x10
9/L. At laparoscopic
surgery, an accessory spleen measuring 4.2x3.5x3.2 cm
was identified and easily removed (Figure 2); histology
demonstrated splenic parenchyma with sinusoidal con-
gestion and expanded red pulp (Figure 3).
RESULTS
The postoperative course was free of complications with
diet resumed on postoperative day 1 and discharge on
postoperative day 2. Platelets rose from 77x10
9/L to
151x10
9/L over the next few days. Unfortunately, platelets
fell back to 20x10
9/L after 2 months; in recent months,
platelet counts average 20x10
9/L with the patient on 10mg
prednisone daily. Therapy for H. pylori failed, and exper-
imental thrombopoietic stimulators are under consider-
ation.
DISCUSSION
Minimally invasive surgery is associated with reduced
postoperative pain, earlier return to normal activity, im-
proved cosmesis, and lower hospital costs compared with
open surgery to treat similar disorders.7,8 Because laparo-
scopic cholecystectomy was shown to meet these criteria
in the late 1980s and early 1990s,9 minimally invasive
surgical techniques have been applied to a variety of
abdominal and thoracic procedures. Since its introduction
in 1992, laparoscopic splenectomy has been shown to be
effective and safe.10,11 The most common indication for
elective splenectomy is ITP. Unfortunately, even when
surgery successfully achieves platelet count remission,
there is no guarantee that the disease will not recur. A
review of the literature shows ITP recurrence following
splenectomy to range between 18% and 38%.12–16 In a
significant number of these patients, residual accessory
splenic tissue can be found.
Accessory spleens have been encountered during open
splenectomies in 14% to 30% of patients.17 Targarona et
al18 reported finding an accessory spleen in 33% of the
patients who did not have clinical improvement after
laparoscopic splenectomy for treatment of ITP. Multiple
modalities for identification of accessory splenic tissue
Figure 1. Computed tomographic scan of the abdomen demon-
strating accessory spleen (arrow).
Figure 2. Intraoperative view of accessory spleen.
Figure 3. Bi-valved accessory spleen.
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accessory splenic tissue in the majority of cases. However,
if there is any uncertainty in the diagnosis based on CT
scan, preoperative nuclear medicine scintigraphy using
heat-damaged Tc99m-labeled red blood cells can be
added to the workup.19 Finally, intraoperative gamma-
probe guidance after injection of Tc99m-labeled red blood
cells can also be used to identify small focuses of splenic
tissue during laparoscopic exploration.20,21
The ultimate question then is whether removal of acces-
sory splenic tissue makes a difference in ITP patients who
have relapsed after splenectomy. The literature provides a
wide disparity in the efficacy of repeat surgery. In open
accessory splenectomy, the response has been reported in
26.7% to 75%.22,23 Similar findings are seen with the lapa-
roscopic approach.19,24,25 Although a complete response
following accessory splenectomy may not be possible,
most patients will realize some benefit from the interven-
tion because of decreased requirements for systemic im-
munosuppressive therapies. A review of the literature
confirms our experience that laparoscopic accessory sple-
nectomy is technically feasible. Szold et al24 reported suc-
cessful laparoscopic accessory splenectomy in 8 of 8 pa-
tients. All patients were discharged on postoperative day
one with no complications. Other studies confirm that
laparoscopic accessory splenectomy is safe and effective.
Morris et al25 reported no conversion to open surgery and
no complications with all discharges on postoperative day
1. Therefore, it seems that the risk benefit ratio favors
laparoscopic resection of residual accessory splenic tissue
in patients with recurrent ITP.
CONCLUSION
Although the initial hematologic response to laparoscopic
accessory splenectomy in this particular case was brief,
there appears to be some degree of long-lasting benefit in
that the patient is now on lower doses of prednisone. This
case documents that laparoscopic resection of residual
splenic tissue in patients with recurrent ITP is safe and
well-tolerated and should be strongly considered in pa-
tients who are refractory to other therapeutic modalities.
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